Azithromycin (ophthalmic): Difference between revisions
Gerald Chi (talk | contribs) mNo edit summary |
Gerald Chi (talk | contribs) mNo edit summary |
||
| Line 17: | Line 17: | ||
==FDA Package Insert== | ==FDA Package Insert== | ||
''' [[Azithromycin description|Description]]''' | ''' [[Azithromycin (ophthalmic) description|Description]]''' | ||
'''| [[Azithromycin clinical pharmacology|Clinical Pharmacology]]''' | '''| [[Azithromycin (ophthalmic) clinical pharmacology|Clinical Pharmacology]]''' | ||
'''| [[Azithromycin microbiology|Microbiology]]''' | '''| [[Azithromycin (ophthalmic) microbiology|Microbiology]]''' | ||
'''| [[Azithromycin indications and usage|Indications and Usage]]''' | '''| [[Azithromycin (ophthalmic) indications and usage|Indications and Usage]]''' | ||
'''| [[Azithromycin contraindications|Contraindications]]''' | '''| [[Azithromycin (ophthalmic) contraindications|Contraindications]]''' | ||
'''| [[Azithromycin warnings and precautions|Warnings and Precautions]]''' | '''| [[Azithromycin (ophthalmic) warnings and precautions|Warnings and Precautions]]''' | ||
'''| [[Azithromycin adverse reactions|Adverse Reactions]]''' | '''| [[Azithromycin (ophthalmic) adverse reactions|Adverse Reactions]]''' | ||
'''| [[Azithromycin clinical studies|Clinical Studies]]''' | '''| [[Azithromycin (ophthalmic) clinical studies|Clinical Studies]]''' | ||
'''| [[Azithromycin dosage and administration|Dosage and Administration]]''' | '''| [[Azithromycin (ophthalmic) dosage and administration|Dosage and Administration]]''' | ||
'''| [[Azithromycin compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | '''| [[Azithromycin (ophthalmic) compatibility reconstitution and stability|Compatibility, Reconstitution, and Stability]]''' | ||
'''| [[Azithromycin how supplied|How Supplied]]''' | '''| [[Azithromycin (ophthalmic) how supplied|How Supplied]]''' | ||
'''| [[Azithromycin labels and packages|Labels and Packages]]''' | '''| [[Azithromycin (ophthalmic) labels and packages|Labels and Packages]]''' | ||
==Mechanism of Action== | ==Mechanism of Action== | ||
Revision as of 20:23, 5 January 2014
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Azithromycin is an azalide, a subclass of macrolide antibiotics. It is derived from erythromycin, with a methyl-substituted nitrogen atom incorporated into the lactone ring, thus making the lactone ring 15-membered.
Category
Macrolide, Azalide
US Brand Names
AZASITE®
FDA Package Insert
Description | Clinical Pharmacology | Microbiology | Indications and Usage | Contraindications | Warnings and Precautions | Adverse Reactions | Clinical Studies | Dosage and Administration | Compatibility, Reconstitution, and Stability | How Supplied | Labels and Packages
Mechanism of Action
Azithromycin prevents bacteria from growing by interfering with their protein synthesis. It binds to the 50S subunit of the bacterial ribosome, and thus inhibits translation of mRNA. Nucleic acid synthesis is not affected.[1]
References
- ↑ "azithromycin (Zithromax, Zmax, Z-Pak) - Side Effects, Drug Interactions". MedicineNet. Retrieved 2013-01-06.